The Platform

A cloud-native SaaS platform built for the regulatory reality of health data.

UndosaTech unifies fragmented biomedical datasets with no-code AI tools — inside HIPAA- and GDPR-aligned frameworks. Sign in with your institutional or Google account.

Core Architecture

The intelligence
travels to the data.

Traditional approaches centralise or share raw patient data. UndosaTech reverses the model. AI models travel to local institutional servers to train. Only aggregated model updates are shared — no raw records, ever.

🏥
Institution
Data stays on-premises behind existing governance. Zero raw transfer. Full institutional control at every step.
🧠
Federated Model
The AI model trains locally. Only encrypted weight updates leave — never patient records.
🔗
Aggregation
Global model improves across institutions. Governance and consent honoured throughout, with full audit trail.
Platform Capabilities

Everything research needs.

01
Zero-Trust Federated Learning
AI models travel to local servers. Datasets never leave. Designed for GDPR, HIPAA, and EHDS compliance with full audit trails.
GDPRHIPAAEHDS
02
No-Code AI for Domain Experts
Automated model building, computer vision, and deep learning workflows — so neuroscientists and clinicians stay in charge of the science, not data engineers.
03
Enterprise Regulatory Compliance
Automated data lineage, audit trails, and PCCP support for FDA submissions. Built for the NHS and EHDS Secure Processing Environment from day one.
FDA PCCPNHS IG
04
Research Data Reuse Programme
A governed framework enabling institutions to make archived and unpublished data available for ethical secondary analysis — under their own governance.
Regulatory Alignment

Compliance is
the architecture.

Designed natively for the frameworks governing health data research across the NHS, EU Health Data Space, and FDA. Not retrofitted — built this way from day one.

GDPRHIPAAEU Health Data SpaceNHS IGFDA PCCPEHDS SPE
Research Areas

Rooted in real
neuroscience research.

UndosaTech emerged from a literature review into the role of Substance P in the axial elongation of myopia. The fragmentation encountered is the exact problem this platform solves.

Alzheimer's & DementiaParkinson's DiseaseNeurodegenerationVision Science & Retinal ImagingMyopia ResearchTreatment-Resistant DepressionChronic PainSubstance P
Try the Demo → Request Access